Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenna H Newman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Pharmacology Reports|December 5, 2017
Infection: a Cause of and Cure for CancerJenna H Newman, Andrew Zloza
Trends in Immunology|March 6, 2021
Uncloaking Breast Tumor Neoantigens with RadiationJenna H Newman, Nina Bhardwaj
Nature Communications|March 8, 2024
Structural basis for self-discrimination by neoantigen-specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Research Square|February 13, 2023
Structural Basis for Self-Discrimination by Neoantigen-Specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Gut Microbial Shifts Indicate Melanoma Presence and Bacterial Interactions in a Murine ModelMarco Rossi, Salvatore M Aspromonte, Frederick J Kohlhapp, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Natural Killer Cell Dysfunction In Human Bladder Cancer Is Caused By Tissue-Specific Suppression of SLAMF6 SignalingAdam M Farkas, Dina Youssef, Michelle A Tran, et al.
The Journal of Clinical Investigation|March 14, 2018
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitmentJessica Wagner, C Leah Kline, Lanlan Zhou, et al.
Oncogene|April 7, 2018
Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancerJenna H Newman, David J Augeri, Rachel NeMoyer, et al.
Journal for Immunotherapy of Cancer|July 11, 2023
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancerSachin R Jhawar, Shang-Jui Wang, Aditya Thandoni, et al.
Cell Reports|October 21, 2016
Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host DeathFrederick J Kohlhapp, Erica J Huelsmann, Andrew T Lacek, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Pharmacology Reports|December 5, 2017
Infection: a Cause of and Cure for CancerJenna H Newman, Andrew Zloza
Trends in Immunology|March 6, 2021
Uncloaking Breast Tumor Neoantigens with RadiationJenna H Newman, Nina Bhardwaj
Nature Communications|March 8, 2024
Structural basis for self-discrimination by neoantigen-specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Research Square|February 13, 2023
Structural Basis for Self-Discrimination by Neoantigen-Specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Gut Microbial Shifts Indicate Melanoma Presence and Bacterial Interactions in a Murine ModelMarco Rossi, Salvatore M Aspromonte, Frederick J Kohlhapp, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Natural Killer Cell Dysfunction In Human Bladder Cancer Is Caused By Tissue-Specific Suppression of SLAMF6 SignalingAdam M Farkas, Dina Youssef, Michelle A Tran, et al.
The Journal of Clinical Investigation|March 14, 2018
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitmentJessica Wagner, C Leah Kline, Lanlan Zhou, et al.
Oncogene|April 7, 2018
Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancerJenna H Newman, David J Augeri, Rachel NeMoyer, et al.
Journal for Immunotherapy of Cancer|July 11, 2023
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancerSachin R Jhawar, Shang-Jui Wang, Aditya Thandoni, et al.
Cell Reports|October 21, 2016
Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host DeathFrederick J Kohlhapp, Erica J Huelsmann, Andrew T Lacek, et al.
Pageof 2